DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» China Nepstar
China Nepstar
Inside This Issue
China Digest
China Nepstar Chain Drugstore Ltd
Annual Report 2017
Sinopharm Group: 2H14 NDR Takeaways: Margin Expansion To
Company Report Hong Kong Equity Research
Sinopharm Group Co Ltd PERFORM 12-18 Mo
“Profiting from China's Fast-Growing Retail Pharmaceutical Industry”
Outlook on China's Pharmaceutical Distribution Market 2019-2025 - Cross- Border Integration of Pharmaceuticals & E-Commerce Continues
Procter & Gamble Teams with Teva in OTC Market
Acquisition of Finished Drug Businesses Reduces Bulk Exposure
2013 Outlook 10 December 2012 Health Care Industry Update
Healthcare in China Entering Uncharted Waters
Tender Watcher – Drugs: Guangdong Tender Rules Changed Again (For
European When China European Equities, China Stalls
Chinese Cross-Listing Lixian
Pharma China0108-285.P65
Pharmaceutical Distribution Market Analysis
Top View
China Pharmaceutical Distribution Industry Report, 2019-2025
Chinese “Squeeze Outs” in American Stock Markets and the Need to Protect U.S
Registration Period for Asia-Pacific & China Companies for the 2012 IR
China Healthcare | November 27, 2015 MORGAN STANLEY RESEARCH
China Nepstar Chain Drugstore Ltd. NYSE:NPD
HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL July 2015
The Way Chinese Companies Collaborate with Chinese Universities
Delrapport 3 Om Apotekens Lönsamhet
PW Medtech: 2H14 Missed; Lowering PT on Weaker Organic Growth
HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL August 2015
上海醫藥集團股份有限公司 Shanghai Pharmaceuticals Holding Co., Ltd